Report cover image

Claudin 18.2 Targeted Therapy Global Market Report 2025

Publisher The Business Research Company
Published Oct 23, 2025
Length 250 Pages
SKU # BRC20492400

Description

Claudin 18.2 Targeted Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on claudin 18.2 targeted therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for claudin 18.2 targeted therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The claudin 18.2 targeted therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Therapy Type: Monoclonal Antibodies; Bispecific Antibodies; Antibody-Drug Conjugates; Other Therapy Types

2) By Indication: Gastric Cancer; Pancreatic Cancer; Esophageal Cancer; Other Indications

3) By Route Of Administration: Intravenous; Oral; Other Route Of Administrations

4) By End-User: Hospitals; Oncology Centers; Research Institutes; Other End-Users

Subsegments:

1) By Monoclonal Antibodies: Chimeric Monoclonal Antibodies; Humanized Monoclonal Antibodies; Fully Human Monoclonal Antibodies

2) By Bispecific Antibodies: Igg-Like Bispecific Antibodies; Non-Igg-Like Bispecific Antibodies

3) By Antibody-Drug Conjugates: Microtubule Inhibitor-Based Antibody-Drug Conjugates; Dna Damaging Agent-Based Antibody-Drug Conjugates; Topoisomerase Inhibitor-Based Antibody-Drug Conjugates

4) By Other Therapy Types: Car-T Cell Therapy; Vaccines; Small Molecule Inhibitors

Companies Mentioned: Bristol Myers Squibb Company; Amgen Inc.; Astellas Pharma Inc.; Jiangsu Hengrui Medicine Co. Ltd.; Shanghai Henlius Biotech Inc.; Legend Biotech Corporation; Zai Lab Limited; Harbour Biomed Ltd.; CARsgen Therapeutics Holdings Limited; Genor Biopharma Co. Ltd.; Phanes Therapeutics Inc.; Suzhou Zelgen Biopharmaceuticals Co. Ltd.; Triumvira Immunologics Inc.; SOTIO Biotech a.s.; Leap Therapeutics; Allogene Therapeutics; AskGene Pharma Inc.; Elpiscience Biopharmaceutical Co. Ltd.; I-Mab Biopharma Co. Ltd.; Antegene Biopharma Co. Ltd.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Claudin 18.2 Targeted Therapy Market Characteristics
3. Claudin 18.2 Targeted Therapy Market Trends And Strategies
4. Claudin 18.2 Targeted Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Claudin 18.2 Targeted Therapy Growth Analysis And Strategic Analysis Framework
5.1. Global Claudin 18.2 Targeted Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Claudin 18.2 Targeted Therapy Market Growth Rate Analysis
5.4. Global Claudin 18.2 Targeted Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Claudin 18.2 Targeted Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Claudin 18.2 Targeted Therapy Total Addressable Market (TAM)
6. Claudin 18.2 Targeted Therapy Market Segmentation
6.1. Global Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Bispecific Antibodies
Antibody-Drug Conjugates
Other Therapy Types
6.2. Global Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gastric Cancer
Pancreatic Cancer
Esophageal Cancer
Other Indications
6.3. Global Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous
Oral
Other Route Of Administrations
6.4. Global Claudin 18.2 Targeted Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Oncology Centers
Research Institutes
Other End-Users
6.5. Global Claudin 18.2 Targeted Therapy Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chimeric Monoclonal Antibodies
Humanized Monoclonal Antibodies
Fully Human Monoclonal Antibodies
6.6. Global Claudin 18.2 Targeted Therapy Market, Sub-Segmentation Of Bispecific Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Igg-Like Bispecific Antibodies
Non-Igg-Like Bispecific Antibodies
6.7. Global Claudin 18.2 Targeted Therapy Market, Sub-Segmentation Of Antibody-Drug Conjugates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Microtubule Inhibitor-Based Antibody-Drug Conjugates
Dna Damaging Agent-Based Antibody-Drug Conjugates
Topoisomerase Inhibitor-Based Antibody-Drug Conjugates
6.8. Global Claudin 18.2 Targeted Therapy Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Car-T Cell Therapy
Vaccines
Small Molecule Inhibitors
7. Claudin 18.2 Targeted Therapy Market Regional And Country Analysis
7.1. Global Claudin 18.2 Targeted Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Claudin 18.2 Targeted Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Claudin 18.2 Targeted Therapy Market
8.1. Asia-Pacific Claudin 18.2 Targeted Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Claudin 18.2 Targeted Therapy Market
9.1. China Claudin 18.2 Targeted Therapy Market Overview
9.2. China Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Claudin 18.2 Targeted Therapy Market
10.1. India Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Claudin 18.2 Targeted Therapy Market
11.1. Japan Claudin 18.2 Targeted Therapy Market Overview
11.2. Japan Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Claudin 18.2 Targeted Therapy Market
12.1. Australia Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Claudin 18.2 Targeted Therapy Market
13.1. Indonesia Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Claudin 18.2 Targeted Therapy Market
14.1. South Korea Claudin 18.2 Targeted Therapy Market Overview
14.2. South Korea Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Claudin 18.2 Targeted Therapy Market
15.1. Western Europe Claudin 18.2 Targeted Therapy Market Overview
15.2. Western Europe Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Claudin 18.2 Targeted Therapy Market
16.1. UK Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Claudin 18.2 Targeted Therapy Market
17.1. Germany Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Claudin 18.2 Targeted Therapy Market
18.1. France Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Claudin 18.2 Targeted Therapy Market
19.1. Italy Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Claudin 18.2 Targeted Therapy Market
20.1. Spain Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Claudin 18.2 Targeted Therapy Market
21.1. Eastern Europe Claudin 18.2 Targeted Therapy Market Overview
21.2. Eastern Europe Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Claudin 18.2 Targeted Therapy Market
22.1. Russia Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Claudin 18.2 Targeted Therapy Market
23.1. North America Claudin 18.2 Targeted Therapy Market Overview
23.2. North America Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Claudin 18.2 Targeted Therapy Market
24.1. USA Claudin 18.2 Targeted Therapy Market Overview
24.2. USA Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Claudin 18.2 Targeted Therapy Market
25.1. Canada Claudin 18.2 Targeted Therapy Market Overview
25.2. Canada Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Claudin 18.2 Targeted Therapy Market
26.1. South America Claudin 18.2 Targeted Therapy Market Overview
26.2. South America Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Claudin 18.2 Targeted Therapy Market
27.1. Brazil Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Claudin 18.2 Targeted Therapy Market
28.1. Middle East Claudin 18.2 Targeted Therapy Market Overview
28.2. Middle East Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Claudin 18.2 Targeted Therapy Market
29.1. Africa Claudin 18.2 Targeted Therapy Market Overview
29.2. Africa Claudin 18.2 Targeted Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Claudin 18.2 Targeted Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Claudin 18.2 Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Claudin 18.2 Targeted Therapy Market Competitive Landscape And Company Profiles
30.1. Claudin 18.2 Targeted Therapy Market Competitive Landscape
30.2. Claudin 18.2 Targeted Therapy Market Company Profiles
30.2.1. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Jiangsu Hengrui Medicine Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Shanghai Henlius Biotech Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Claudin 18.2 Targeted Therapy Market Other Major And Innovative Companies
31.1. Legend Biotech Corporation
31.2. Zai Lab Limited
31.3. Harbour Biomed Ltd.
31.4. CARsgen Therapeutics Holdings Limited
31.5. Genor Biopharma Co. Ltd.
31.6. Phanes Therapeutics Inc.
31.7. Suzhou Zelgen Biopharmaceuticals Co. Ltd.
31.8. Triumvira Immunologics Inc.
31.9. SOTIO Biotech a.s.
31.10. Leap Therapeutics
31.11. Allogene Therapeutics
31.12. AskGene Pharma Inc.
31.13. Elpiscience Biopharmaceutical Co. Ltd.
31.14. I-Mab Biopharma Co. Ltd.
31.15. Antegene Biopharma Co. Ltd.
32. Global Claudin 18.2 Targeted Therapy Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Claudin 18.2 Targeted Therapy Market
34. Recent Developments In The Claudin 18.2 Targeted Therapy Market
35. Claudin 18.2 Targeted Therapy Market High Potential Countries, Segments and Strategies
35.1 Claudin 18.2 Targeted Therapy Market In 2029 - Countries Offering Most New Opportunities
35.2 Claudin 18.2 Targeted Therapy Market In 2029 - Segments Offering Most New Opportunities
35.3 Claudin 18.2 Targeted Therapy Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us